Search results
Anavex (AVXL) Up 12% on Regulatory Update for Alzheimer's Drug
Zacks via Yahoo Finance· 6 months agoAnavex (AVXL) announces an encouraging regulatory update for its investigational candidate,...
Anavex (AVXL): Strong Industry, Solid Earnings Estimate Revisions
Zacks via Yahoo Finance· 4 months agoOne stock that might be an intriguing choice for investors right now is Anavex Life Sciences Corp....
Anavex (AVXL) Falls 35% on Mixed Rett Syndrome Study Results
Zacks via Yahoo Finance· 5 months agoAnavex (AVXL) falls 35% on mixed results from the mid to late-stage study of 30 mg ANAVEX2-73 for...
Why Endo (ENDP) Stock Wilted After its Surge on Tuesday?
Zacks via Yahoo Finance· 2 years agoEndo International (ENDO) tanks 26%, cooling off after its massive stock price surge on Tuesday,...
Anavex's (AVXL) Lead Alzheimer's Drug Meets Study Goal
Zacks via Yahoo Finance· 1 year agoTop-line data from a phase IIb/III study shows that Anave's (AVXL) lead drug exhibited statistical...
Immunovant (IMVT) Sees Wider Q4 Loss, to Study Batoclimab in TED
Zacks via Yahoo Finance· 2 years agoImmunovant's (IMVT) earnings miss estimates in fiscal fourth quarter ended on Mar 31, 2022. The...
Global Blood (GBT) Initiates Phase II Study on SCD Candidate
Zacks via Yahoo Finance· 2 years agoGlobal Blood Therapeutics (GBT) initiates the phase II portion of its planned phase II/III studies...
Celldex (CLDX) Initiates Phase II Chronic Skin Disorder Study
Zacks via Yahoo Finance· 2 years agoCelldex (CLDX) initiates dosing in a mid-stage study designed to evaluate its antibody candidate,...
Protagonist (PTGX) Up 14% on Licensing Deal With Takeda
Zacks via Yahoo Finance· 4 months agoPer the deal, Protagonist (PTGX) will grant exclusive rights to Takeda to market its late-stage rare...
Acadia (ACAD) Gets FDA Approval for Daybue for Rett Syndrome
Zacks via Yahoo Finance· 1 year agoAcadia Therapeutics (ACAD) announces the FDA approval of its Rett Syndrome drug, trofinetide, for...